Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • SBI

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
SBI
UPCOMING EVENT:Are you 45+? Planning for retirement? We have just the right webinar for you - Planning for Retirement with Life Insurance on 27-Jan, 3pm. Register now!
you are here: HomeNewsBusiness

JSW Steel bumps up combined crude steel output by 28% for December quarter year-on-year

Sequentially, the combined output rose six percent, the company said in a press release.

January 11, 2022 / 10:50 AM IST

JSW Steel today reported a 28 percent year-on-year growth in its combined crude steel output for the quarter ended December at 5.35 million tonnes.

Sequentially, the combined output rose six percent, the company said in a press release. 

On a standalone basis, the company recorded production of 4.41 million tonnes, registering a sequential and year-on-year growth of eight percent each.

Capacity use at the standalone level was 94% during the December quarter.

Output would have been higher had it not been for Bhushan Power & Steel’s continuous strip plant being shut down for 10 days for upgrade, the company said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

For the nine-month period of April-December, the company recorded crude steel production growth of 15 percent on a standalone basis at 12.61 million tonnes and 39 percent at the group level at 15.50 million tonnes.

 
Moneycontrol News
Sections
ISO 27001 - BSI Assurance Mark